VEGFR2/CD309 Rekombinanter Antikörper
VEGFR2/CD309 Rekombinant Antikörper für FC
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
Maus
Anwendung
FC
Konjugation
Unkonjugiert
CloneNo.
240214D7
Kat-Nr. : 98027-2-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
98027-2-PBS bindet in FC VEGFR2/CD309 und zeigt Reaktivität mit Maus
| Getestete Reaktivität | Maus |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | Fusionsprotein |
| Vollständiger Name | kinase insert domain protein receptor |
| Berechnetes Molekulargewicht | 150KD |
| GenBank-Zugangsnummer | NM_010612.2 |
| Gene symbol | VEGFR-2 |
| Gene ID (NCBI) | 16542 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein A purfication |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. |
Hintergrundinformationen
VEGFR2, also named as CD309, KDR and FLK1, is a receptor for VEGF or VEGFC. VEGFR2 which belongs to the protein kinase superfamily, has a tyrosine-protein kinase activity. The VEGF-kinase ligand/receptor signaling system plays a key role in vascular development and regulation of vascular permeability. In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions. VEGFR2 functions as the main mediator of VEGF-induced endothelial proliferation, survival, migration, tubular morphogenesis and sprouting. Mutations of this gene are implicated in infantile capillary hemangiomas.



